AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions
about
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular eventsPlatelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery diseaseThe oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitusAspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study.Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysisAntiplatelet combinations for prevention of atherothrombotic eventsAntiplatelet therapy for every diabetic person?The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.Aspirin resistance in patients with type II diabetes mellitus.Gender differences in the primary prevention of stroke with aspirin.Aspirin for primary prevention of cardiovascular events in the elderly: current status and future directions.Overcoming aspirin treatment failure in diabetes.Updates in antiplatelet agents used in cardiovascular diseases.Platelets, diabetes and myocardial ischemia/reperfusion injury.Aspirin in the prevention of cardiovascular events in patients with diabetes.Effect of omega 3 fatty acids plus low-dose aspirin on both clinical and biochemical profiles of patients with chronic periodontitis and type 2 diabetes: a randomized double blind placebo-controlled study.Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs.An aspirin a day: are we barking up the wrong willow tree?Myocardial infarction and gastro-intestinal bleeding risks associated with aspirin use among elderly individuals with type 2 diabetes.Cardiovascular prevention in clinical practice (ESC and German guidelines 2007).Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study.
P2860
Q26995752-624D75C3-1205-4A84-8F3C-CB441787597EQ27027247-73CE07B8-F96E-49CE-B4BD-D1A683A8FAEDQ33405692-0CA1686B-C3F7-49B9-9B38-433B3B346EB9Q33515541-5B03C2E0-2BAE-4923-8E95-8B4B57184917Q33602214-05AE759E-B235-4624-A993-85A9849E5E89Q33859058-09DD1FC7-C0E6-4060-9A46-9E6005DA6530Q34566264-9517D0AB-73E8-4C14-B239-9542D13E980BQ36783726-24CBD9EB-F305-46ED-BE22-478A8CBE08D3Q37326570-A3F3622E-5F1E-4A2F-9C64-2916E8B6670AQ37564161-88B2063E-6DA3-4194-8550-57F5972C80BEQ37879676-EE537079-1DAB-42A7-A4A3-DCAD2C7B55D3Q37998509-58CA6C35-5E8B-4925-A23E-009B817C68FBQ38055245-4713C1BA-0154-45DE-B20D-92AD867947CCQ38161394-98222BBA-67E7-4DEB-810A-52DB6E0E6C0EQ39343342-2C313AC1-9476-4372-A344-E5C8722668F3Q40225996-4F550654-7D2A-4718-842A-AFDC7EA2BE06Q41554270-F41EB7B6-BF5D-4B36-A90C-152164C0D3F5Q42795171-A7757D04-C8DC-46A7-A688-AFBF8FF975DBQ43184658-683A586E-BBED-4EB8-9C0C-0C48292F44B6Q43563736-A1EAC8FB-A0E8-4F54-90E3-D42BB71828EBQ46123311-7308D8FB-831F-4E29-8BD2-721213B880C8Q47365819-0710AD60-D9C2-4B5F-A8D7-46C1055CDAAF
P2860
AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
AHA/ADA vs. ESC/EASD recommend ...... generate divergent conclusions
@ast
AHA/ADA vs. ESC/EASD recommend ...... generate divergent conclusions
@en
AHA/ADA vs. ESC/EASD recommend ...... generate divergent conclusions
@nl
type
label
AHA/ADA vs. ESC/EASD recommend ...... generate divergent conclusions
@ast
AHA/ADA vs. ESC/EASD recommend ...... generate divergent conclusions
@en
AHA/ADA vs. ESC/EASD recommend ...... generate divergent conclusions
@nl
prefLabel
AHA/ADA vs. ESC/EASD recommend ...... generate divergent conclusions
@ast
AHA/ADA vs. ESC/EASD recommend ...... generate divergent conclusions
@en
AHA/ADA vs. ESC/EASD recommend ...... generate divergent conclusions
@nl
P50
P356
P1476
AHA/ADA vs. ESC/EASD recommend ...... generate divergent conclusions
@en
P2093
Michele Sacco
P304
P356
10.1093/EURHEARTJ/EHM248
P407
P577
2007-08-01T00:00:00Z